Screening for lung cancer: Another look; A different view

Chest

Volumn 111, Issue 3, 1997, Pages 754-768

  Strauss, Gary M ^a,d   Gleason, Ray E ^a   Sugarbaker, David J ^a   Caro, ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c Caro Research   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG CARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

EID: 0030899751     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.3.754     Document Type: Article

References (93)

1. Richert-Boe K, Humphrey LL. Screening for cancers of the lung and colon. Arch Intern Med 1992; 152:2398-2404
2. American Cancer Society. Report on the cancer-related health checkup: cancer of the lung. CA Cancer J Clin 1980; 30:199-207
3. Eddy D. Screening for lung cancer. Ann Intern Med 1989; 111:232-37
4. American Cancer Society. 1989 survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1990; 40:77-101
5. American Cancer Society. 1984 survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1985; 35:197-213
6. Carbone PP, Frost JK, Feinstein AR, et al. Lung cancer: perspectives and prospects. Ann Intern Med 1970; 73:1003-24
7. Silverberg E, Cancer statistics - 1980. CA Cancer J Clin 1980; 30:23-38
8. Parker SL, Tong T, Bolden S, et al. Cancer statistics - 1996. CA Cancer J Clin 1996; 46:5-27
9. Morrisou A. Screening in chronic disease. 2nd ed. New York: Oxford University Press, 1992
10. Hulka B. Cancer screening: degrees of proof and practical application. Cancer 1988; 62:1776-80
11. Weiss W, Boucot KR, Cooper DA. The Philadelphia Pulmonary Neoplasm Research Project: survival factors in bronchogenic carcinoma. JAMA 1971; 216:2119-23
12. Weiss W, Boucot KR. The Philadelphia Pulmonary Neoplasm Research Project: early roentgenographic appearance of bronchogenic carcinoma. Arch Intern Med 1974; 134:306-11
13. Boucot KR, Weiss W. Is curable lung cancer detected by semiannual screening? JAMA 1973; 224:1361-65
14. Lilienfeld A, Archer PG, Burnett CH, et al. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: a cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res 1966; 26:2083-2121
15. Hayata Y, Funatsu H, Kato H, et al. Results of lung cancer screening programs in Japan: early detection and localization of lung tumors in high risk groups. In: Band PR, ed. Recent results of cancer research (vol 82). Heidelberg: Springer Berlin, 1982; 179-86
16. Nash KA, Morgan JM, Tomkins JG. South London Lung Cancer Study. BMJ 1968; 2:715-21
17. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern 30 day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86:654-57
18. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968; 23:414-20
19. Brett GZ. Earlier diagnosis and survival in lung cancer. BMJ 1969; 4:260-62
20. Wilde J. A 10 year follow-up of semiannual screening for early detection of lung cancer in the Erfurt county, GDR. Eur Respir J 1989; 2:656-62
21. Berlin NJ, Buncher CR, Fontana RS, et al. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Am Rev Respir Dis 1984; 130:545-49
22. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung cancer: results of the Memorial-Sloan Kettering study in New York. Chest 1984; 86:44-53
23. Flehinger BJ, Melamed MR, Zaman MB, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984; 130:555-60
24. National Lung Program - Memorial Sloan-Kettering Cancer Center. Final report and data summary. Bethesda, Md: National Cancer Institute, 1984
25. Tockman M. Survival and mortality from lung cancer in a screened population: the John Hopkins study. Chest 1986; 89:325S-26S
26. Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130:549-54
27. Levin ML, Tockman MS, Frost JK, et al. Lung cancer mortality in males screened by chest x-ray and cytologic sputum examination: a preliminary report. In: Band P, ed. Early detection and localization of lung tumors in high risk groups: recent results of cancer research (vol 82). Heidelberg: Springer Berlin, 1982; 138-46
28. Fontana RS, Sanderson DH, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984; 130:561-65
29. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1983; 82:70-6
30. Fontana R, Sanderson DH, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med 1986; 28:746-50
31. Fontana HS, Screening for lung cancer. In: Williams AB, ed. Screening for Cancer, Orlando. Fla: Academic Press, 1985; 377-95
32. Fontana R, Sanderson DR, Woolner LB, et al. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 1991; 67:1155-64
33. Kubik A, Polak J. Lung cancer detection: results of a randomised prospective study in Czechoslovakia. Cancer 1986; 57: 2428-37
34. Kubik A, Parkin DM, Khlat M, et al. Lack of benefit from semi-annual screening for cancer of the lung: followup report of a randomized controlled trial on population of high-risk males in Chechoslovakia. Int J Cancer 1990; 45:26-33
35. Kereiakes JC, Rosenstein M. Handbook of radiation doses in nuclear medicine and diagnostic x-ray. Boca Baton, Fla: CRC Press, 1980
36. Webster E. On the question of cancer induction by small x-ray doses. AJR 1981; 137:647-66
37. Cole P, Morrison A. Basic issues in population screening for cancer. J Natl Cancer Inst 1980; 64:1263-72
38. Aron JL, Prorok PC. An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol 1986; 15:36-43
39. Chu K, Smart C, Tarone R. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988; 80:1125-32
40. Fontana RS. Screening for lung cancer: recent experience in the United States. In: Hansen HH, ed. Lung cancer: basic and clinical aspects. Boston: Martinus Nijhoff, 1986; 91-111
41. Wingo PA, Tong T, Bohlen S. Cancer statistics - 1995. CA Cancer J Clin 1995; 45:8-30
42. Humphrey EW, ed. Lung cancer. In: Steele GD, Wincester DP, Menck HR, et al. eds. National cancer base: annual review of patient care. Atlanta: American Cancer Society, 1992; 19-28
43. Myers MH, Gloeckler Ries LA. Cancer patient survival rates: SEER program results for 10 years of followup. CA Cancer J Clin 1989; 39:21-39
44. Devesa S, Blot W, Stone B, et al. Recent cancer trends in the United States. J Natl Cancer Inst 1995; 87:175-82
45. Cole P, Sateren W. The evolving picture of cancer in America. J Natl Cancer Inst 1995; 87:159-60
46. Kramer BS, Brown ML, Prorok PC, et al. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119:914-23
47. Breslow N, Chan CW, Dhom RA, et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977; 20:680-88
48. Tulinius H. Latent malignancies. In: Grundman E, ed. Cancer epidemiology. New York: Gustav Fisher Verlag, 1982
49. Edwards CN, Steinthorsson E, Nicholson O. An autopsy study of latent prostatic carcinoma. Cancer 1953; 6:531-54
50. Stemmermann GN, Nomura AM, Chyou PH, et al. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience. Cancer Epidemiol Biomarkers Prev 1992; 1:189-93
51. Haas GP, Sakr W, Cassin B, et al. The prevalence of prostate cancer in young black and white males [abstract]. J Urol 1992; 147(suppl):311
52. Sacker WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150:379-85
53. McFarlane MJ, Feinstein AR, Wells CK. Necropsy evidence of detection bias in the diagnosis of lung cancer. Arch Intern Med 1986; 146:1695-98
54. McFarlane MJ, Feinstein AR, Wells CK. Clinical features of lung cancers discovered as a postmortem 'surprise'. Chest 1986; 90:520-23
55. McFarlane MJ, Feinstein AR, Wells CK, et al. The 'epidemiologic necropsy.' JAMA 1987; 258:331-38
56. Johansson J, Adami HO, Anderson SO, et al. High 10-year survival rate in patients with early untreated prostatic cancer. JAMA 1992; 267:2191-96
57. Adolfsson J. Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol 1993; 149:326-39
58. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330:242-48
59. Flehinger BJ, Kimmel M, Melamed MK. The effect of surgical treatment on survival from early lung cancer: implications for screening. Chest 1992; 101:1013-18
60. Flehinger BJ, Kimmel M, Polyak T, et al. Screening for lung cancer: the Mayo Lung Project revisited. Cancer 1993; 72:1573-80
61. Sobue T, Suzuki T, Matsuda M. et al. Survival for clinical stage I lung cancer not surgically treated. Cancer 1992; 69:685-92
62. Farrow DC, Samet JM. Identification of the high-risk smoker. Clin Chest Med 1991; 12:659-68
63. Samet JM. The epidemiology of lung cancer. Chest 1993; 103:20S-9S
64. Beckett WS. Epidemiology and etiology of lung cancer. Clin Chest Med 1993; 14:1-15
65. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking, and death rates. Ann NY Acad Sci 1979; 330:473-90
66. Samet JM. Radon and lung cancer. J Natl Cancer Inst 1989; 81:745-57
67. Skillud DM, Offord KP, Miller RD. High risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med 1986; 105:503-07
68. Sellers TA. Familial predisposition to lung cancer. In: Roth JA, Cox JD, Hong WK, eds. Lung cancer. Boston: Blackwell, 1993; 20-33
69. Shields PG, Harris CC. Genetic predisposition to lung cancer. In: Roth JA, Cox JD, Hong WK, eds. Lung cancer. Boston: Blackwell, 1993; 3-19
70. Kvale G, Bjelke R, Gatt JJ. Dietary habits and lung cancer risk. Int J Cancer 1983; 31:397-405
71. Ziegler RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989; 119:116-22
72. The Alpha-Tochopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin K and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35
73. Omenn GS, Gondman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-55
74. Shields PC, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 1991; 266:681-87
75. Miller AB, Baines CJ, To T, et al. The Canadian National Breast Screening Study: I. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992; 147:1459-76
76. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995; 75:997-1003
77. Baker LH. Breast Cancer Detection and Demonstration Project: five year summary report. CA Cancer J Clin 1982; 32:94-225
78. Seidman H, Gelb SK, Silverberg E, et al. Survival experience in the Breast Cancer Detection and Demonstration Project. CA Cancer J Clin 1987; 37:258-90
79. Eddy D. Screening for breast cancer. Ann Intern Med 1989; 111:389-99
80. Hemekens CH, Buring JE. Contributions of observational evidence and clinical trials in cancer prevention. Cancer 1994; 74:2625-29
81. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-33S
82. Naruke T, Goya T, Tsuchiya H, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-47
83. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. BMJ 1950; 2:739-48
84. Samet JM. Health benefits of smoking cessation. Clin Chest Med 1991; 12:669-79
85. The health benefits of smoking cessation: a report of the Surgeon General. Rockville, Md: US Department of Health and Human Services, 1990
86. Strauss G, DeCamp M, DiBiccaro E, et al. Lung cancer diagnosis is being made with increasing frequency in former cigarette smokers! [abstract 1106]. Proc Am Soc Clin Oncol 1995; 14:362
87. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993; 85:457-64
88. Sobne T, Suzuki T, Fujimoto I, et al. Lung cancer rise among ex-smokers. Jpn J Cancer Res 1991; 82:283-89
89. Strauss CM, Kwiatkowski D, Harpole DH, et al. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J Clin Oncol 1995; 13:1265-79
90. Flehinger BJ, Melemed MR. Current status of screening for lung cancer. Chest Surg Clin N Am 1994; 4:1-15
91. Soda H, Tomita H, Kohom S, et al. Limitation of annual screening radiography for the diagnosis of lung cancer: a retrospective study. Cancer 1993; 72:2341-46
92. Strauss GM, Sugarbaker DS, Caro JJ. Comparative prostate, breast, and lung cancer screening: evidence, policy, practice, and pitfalls [abstract 421]. Proc Am Soc Clin Oncol 1996; 15:195
93. Strauus GM, Langer MP, Elias AD, et al. Multi-modality treatment of stage III non-small cell carcinoma of the lung: a critical review of the literature and strategies for future research. J Clin Oncol 1992; 10:829-38